(Q46919608)

26 December 2017

title

Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter (English)

1 reference

26 December 2017

single-nucleotide polymorphism

main subject

1 reference

Sara M Fitzgerald

1

1 reference

26 December 2017

Rakesh K Goyal

2

1 reference

26 December 2017

William R A Osborne

3

1 reference

26 December 2017

Jennifer D Roy

4

1 reference

26 December 2017

John W Wilson

5

1 reference

26 December 2017

R E Ferrell

6

1 reference

26 December 2017

publication date

31 January 2006

1 reference

26 December 2017

published in

Human Genetics

1 reference

26 December 2017

volume

119

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

276-283

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s00439-006-0142-0

exact match

0 references

cites work

The metabolism of cytosine arabinoside as a predictive test for clinical response to the drug in acute myeloid leukaemia

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00439-006-0142-0

In vitro biochemical tests to evaluate the response to therapy of acute leukemia with cytosine arabinoside or 5-AZA-2'-deoxycytidine

21 January 2018

1 reference

12 December 2020

Metabolism of 1-beta-D-arabinofuranosyluracil in mouse L5178Y cells

1 reference

12 December 2020

Cytidine deaminase and the development of resistance to arabinosyl cytosine.

1 reference

12 December 2020

Human cytidine deaminase: purification of enzyme, cloning, and expression of its complementary DNA

1 reference

12 December 2020

Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro.

1 reference

12 December 2020

Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway

1 reference

12 December 2020

Deoxycytidine kinase and deoxycytidine deaminase values correspond closely to clinical response to cytosine arabinoside remission induction therapy in patients with acute myelogenous leukemia

1 reference

12 December 2020

Design of vectors for efficient expression of human purine nucleoside phosphorylase in skin fibroblasts from enzyme-deficient humans

1 reference

12 December 2020

Long-term expression of human adenosine deaminase in mice after transplantation of bone marrow infected with amphotropic retroviral vectors

1 reference

12 December 2020

Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex

1 reference

12 December 2020

Clinical pharmacology of l-β-D-arabinofuranosyl cytosine

1 reference

12 December 2020

Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemia.

1 reference

12 December 2020

A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity.

1 reference

12 December 2020

Growth inhibition of granulocyte-macrophage colony-forming cells by human cytidine deaminase requires the catalytic function of the protein

1 reference

12 December 2020

Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside

1 reference

12 December 2020

Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside.

1 reference

12 December 2020

Induction of resistance to 1-beta-D-arabinofuranosylcytosine in human H9 cell line by simian immunodeficiency virus

1 reference

12 December 2020

Cloning of a functional cDNA for human cytidine deaminase (CDD) and its use as a marker of monocyte/macrophage differentiation

1 reference

12 December 2020

Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin

1 reference

12 December 2020

Activity of thymidine kinase and of polymerase alpha as well as activity and gene expression of deoxycytidine deaminase in leukemic blasts are correlated with clinical response in the setting of granulocyte-macrophage colony-stimulating factor-based

1 reference

12 December 2020

Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro

1 reference

12 December 2020

Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine

1 reference

12 December 2020

Can multidrug resistance mechanisms be modified?

1 reference

12 December 2020

The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines

1 reference

12 December 2020

Purification of human cytidine deaminase: Molecular and enzymatic characterization and inhibition by synthetic pyrimidine analogs

1 reference

12 December 2020

Recombinant human cytidine deaminase: expression, purification, and characterization

1 reference

12 December 2020

Isolation and characterization of the gene coding for human cytidine deaminase

1 reference

12 December 2020

Nucleoside analogues: mechanisms of drug resistance and reversal strategies.

1 reference

12 December 2020

Expression of cytidine deaminase in human solid tumors and its regulation by 1 alpha,25-dihydroxyvitamin D3.

1 reference

12 December 2020

Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells

1 reference

12 December 2020

10.1007/S00439-006-0142-0

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

16446974

1 reference

26 December 2017